Parexel Named a FlexJobs Top 100 Company to Watch for Telecommuting Jobs in 2016
February 29 2016 - 9:00AM
Business Wire
PAREXEL International Corporation (NASDAQ: PRXL), a leading
global biopharmaceutical services organization, today announced
that it has been named to the FlexJobs Top 100 Companies to Watch
for Telecommuting Jobs in 2016 for the third consecutive year. The
list recognizes companies with a telecommuting-friendly component
to some of their jobs, such as the ability to telecommute entirely
or part of the time.
PAREXEL offers approximately 20 percent of its global employees
flexible work options, including telecommuting, flexible schedules,
and home-based employment. In North America, approximately 40
percent of PAREXEL’s employees take advantage of the Company’s
telecommuting and flexible work opportunities. These employees
represent a diverse cross section of positions, including clinical
research, biostatistics, and regulatory affairs.
“Giving employees telecommuting opportunities and flexible work
options has opened the door for us to find the best and the
brightest talent in the industry. Recruiting the best talent helps
to ensure that we can deliver for our clients,” said Tom
McGoldrick, Vice President of Talent Acquisition, PAREXEL.
“PAREXEL’s varied work options also provide access to a skilled
labor force without geographic restrictions, which is important for
meeting organizational growth and helping our clients simplify
their journey towards bringing new treatments to the patients who
need them around the world.”
PAREXEL has a dedicated “Decentralized Employees Support
Community” on the Company Intranet. The community includes
recommendations for collaboration tools to help employees connect
with each other and advice on setting up a home office. PAREXEL
also offers several training programs for home-based employees.
“PAREXEL is a forward-thinking company that understands that
offering telecommuting options is a smart business strategy," said
Sara Sutton Fell, founder and CEO of FlexJobs. “Telecommuting can
benefit companies in so many ways, including cost savings,
increased productivity and retention, better candidate pools,
enriched company culture, and improved employee health.”
About the RankingFlexJobs, a job service specializing in
remote and flexible job opportunities, analyzed its database of
more than 40,000 companies’ job posting history in 2015 to
determine which companies would be most likely to incorporate
telecommuting into their hiring practices in 2016. To be
considered, companies had to offer a telecommuting-friendly
component to some of their jobs, such as an arrangement to
telecommute entirely, part of the time, or as an option. In 2016,
PAREXEL ranked 18th in the top 100.
About PAREXEL InternationalPAREXEL International
Corporation is a leading global biopharmaceutical services
organization, providing a broad range of expertise-based contract
research, consulting, medical communications, and technology
solutions and services to the worldwide pharmaceutical,
biotechnology and medical device industries. Committed to providing
solutions that expedite time-to-market and peak-market penetration,
PAREXEL has developed significant expertise across the development
and commercialization continuum, from drug development and
regulatory consulting to clinical pharmacology, clinical trials
management, medical education and reimbursement. PAREXEL
Informatics provides advanced technology solutions, including
medical imaging, to facilitate the clinical development process.
Headquartered near Boston, Massachusetts, PAREXEL has offices in 77
locations in 51 countries around the world, and had approximately
18,200 employees in the second quarter. For more information about
PAREXEL International visit www.PAREXEL.com.
PAREXEL is a registered trademark of PAREXEL International
Corporation. All other trademarks are the property of their
respective owners.
This release contains “forward-looking” statements regarding
future results and events. For this purpose, any statements
contained herein that are not statements of historical fact may be
deemed forward-looking statements. Without limiting the foregoing,
the words “believes,” “anticipates,” “plans,” “expects,” “intends,”
“appears,” “estimates,” “projects,” “will,” “would,” “could,”
“should,” “targets,” and similar expressions are also intended to
identify forward-looking statements. The forward-looking statements
in this release involve a number of risks and uncertainties. Such
factors and others are discussed in the section entitled “Risk
Factors” of the Company’s most recent Annual Report on Form 10-K
and subsequent quarterly reports on Form 10-Q as filed with the
Securities and Exchange Commission, which “Risk Factors” discussion
is incorporated by reference in this press release. The Company
specifically disclaims any obligation to update these
forward-looking statements in the future. These forward-looking
statements should not be relied upon as representing the Company’s
estimates or views as of any date subsequent to the date of this
press release.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160229005227/en/
PAREXEL InternationalCristi Barnett, +1
781-434-4019Cristi.Barnett@PAREXEL.comorPAN CommunicationsMatthew
Briggs, +1 617-502-4300PAREXEL@pancomm.com
Parexel (NASDAQ:PRXL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Parexel (NASDAQ:PRXL)
Historical Stock Chart
From Apr 2023 to Apr 2024